Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for pain reduction during prostate biopsy
IRCT20200205046388N1Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of pregabalin and lidocaine in prostate biopsy pain (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoint: Pain after prostate biopsy. Started Nov 2020; status: completed.
02
Drugs
pregabalinlidocaine
03
Conditions
prostate biopsy pain
Beyond the preview
Go deeper on IRCT20200205046388N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200205046388N1.